Epstein Secrets

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

tlets, running similar analyses. To the New York Times <https://www.nytimestotn/2020/09/22/us/politics/ruth-bader-ginsburg- republicans.html> (9/22, Fandos, 18.61M), "Romney's decision capped off an extraordinarily swift and enthusiastic rally by Republicans around Mr. Trump's position that underscored

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

K), and Breitbart (9/22, Bleau, 673K), among other conservative news outlets, running similar analyses. EFTA00149080 To the New York Times (9/22, Fandos, 18.61M), "Romney's decision capped off an extraordinarily swift and enthusiastic rally by Republicans around Mr. Trump's position that underscored

starting Monday." Bloomberg adds that according to Mkhize, "the government will start a mass vaccination effort at 87 sites across the country using Pfizer Inc. doses administered to frontline health-care workers and the elderly." Pandemic Leading To Refugee Waves Across World. The New York Times (5/16, Jo

cluding an unrelated incident in April when a motorist rammed a car into a pair of Capitol Police officers, killing one." The New York Times (5/14, Fandos, 20.6M) reports that Democrats also "plan to move ahead with a vote on a bill that would provide $1.9 billion to bolster the Capitol's defenses and

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

2, Rodgers, 716K), and Breitbart (9/22, Bleau, 673K), among other conservative news outlets, running similar analyses. To the New York Times (9/22, Fandos, 18.61M), "Romney's decision capped off an extraordinarily swift and enthusiastic rally by Republicans around Mr. Trump's position that underscored